Literature DB >> 21747386

Next-generation flow cytometry.

Matthew R Janes, Christian Rommel.   

Abstract

Mesh：

Year:  2011        PMID： 21747386     DOI： 10.1038/nbt.1919

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  9 in total

Review 1.  Seventeen-colour flow cytometry: unravelling the immune system.

Authors:  Stephen P Perfetto; Pratip K Chattopadhyay; Mario Roederer
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

2.  An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis.

Authors:  Michael E Weinblatt; Arthur Kavanaugh; Mark C Genovese; Theresa K Musser; Elliott B Grossbard; Daniel B Magilavy
Journal:  N Engl J Med       Date:  2010-09-22       Impact factor: 91.245

3.  8 color, 10-parameter flow cytometry to elucidate complex leukocyte heterogeneity.

Authors:  M Roederer; S De Rosa; R Gerstein; M Anderson; M Bigos; R Stovel; T Nozaki; D Parks; L Herzenberg; L Herzenberg
Journal:  Cytometry       Date:  1997-12-01

4.  The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy.

Authors:  Lee A Honigberg; Ashley M Smith; Mint Sirisawad; Erik Verner; David Loury; Betty Chang; Shyr Li; Zhengying Pan; Douglas H Thamm; Richard A Miller; Joseph J Buggy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

5.  Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum.

Authors:  Sean C Bendall; Erin F Simonds; Peng Qiu; El-ad D Amir; Peter O Krutzik; Rachel Finck; Robert V Bruggner; Rachel Melamed; Angelica Trejo; Olga I Ornatsky; Robert S Balderas; Sylvia K Plevritis; Karen Sachs; Dana Pe'er; Scott D Tanner; Garry P Nolan
Journal:  Science       Date:  2011-05-06       Impact factor: 47.728

6.  Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis.

Authors:  Srdan Verstovsek; Hagop Kantarjian; Ruben A Mesa; Animesh D Pardanani; Jorge Cortes-Franco; Deborah A Thomas; Zeev Estrov; Jordan S Fridman; Edward C Bradley; Susan Erickson-Viitanen; Kris Vaddi; Richard Levy; Ayalew Tefferi
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

7.  CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability.

Authors:  Brian J Lannutti; Sarah A Meadows; Sarah E M Herman; Adam Kashishian; Bart Steiner; Amy J Johnson; John C Byrd; Jeffrey W Tyner; Marc M Loriaux; Mike Deininger; Brian J Druker; Kamal D Puri; Roger G Ulrich; Neill A Giese
Journal:  Blood       Date:  2010-10-19       Impact factor: 22.113

8.  Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry.

Authors:  Dmitry R Bandura; Vladimir I Baranov; Olga I Ornatsky; Alexei Antonov; Robert Kinach; Xudong Lou; Serguei Pavlov; Sergey Vorobiev; John E Dick; Scott D Tanner
Journal:  Anal Chem       Date:  2009-08-15       Impact factor: 6.986

Review 9.  Detection, clinical relevance and specific biological properties of disseminating tumour cells.

Authors:  Klaus Pantel; Ruud H Brakenhoff; Burkhard Brandt
Journal:  Nat Rev Cancer       Date:  2008-05       Impact factor: 60.716
  9 in total
  5 in total

Review 1.  Emerging proteomic technologies for elucidating context-dependent cellular signaling events: A big challenge of tiny proportions.

Authors:  Sarah J Parker; Koen Raedschelders; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2015-02-10       Impact factor: 3.984

2.  Metal-isotope-tagged monoclonal antibodies for high-dimensional mass cytometry.

Authors:  Guojun Han; Matthew H Spitzer; Sean C Bendall; Wendy J Fantl; Garry P Nolan
Journal:  Nat Protoc       Date:  2018-10       Impact factor: 13.491

3.  Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells.

Authors:  Marco Orecchioni; Davide Bedognetti; Leon Newman; Claudia Fuoco; Filomena Spada; Wouter Hendrickx; Francesco M Marincola; Francesco Sgarrella; Artur Filipe Rodrigues; Cécilia Ménard-Moyon; Gianni Cesareni; Kostas Kostarelos; Alberto Bianco; Lucia G Delogu
Journal:  Nat Commun       Date:  2017-10-24       Impact factor: 14.919

4.  A theorem proving approach for automatically synthesizing visualizations of flow cytometry data.

Authors:  Sunny Raj; Faraz Hussain; Zubir Husein; Neslisah Torosdagli; Damla Turgut; Narsingh Deo; Sumanta Pattanaik; Chung-Che Jeff Chang; Sumit Kumar Jha
Journal:  BMC Bioinformatics       Date:  2017-06-07       Impact factor: 3.169

5.  MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells.

Authors:  Zhihong Zeng; Rui-Yu Wang; Yi Hua Qiu; Duncan H Mak; Kevin Coombes; Suk Young Yoo; Qi Zhang; Katti Jessen; Yi Liu; Christian Rommel; David A Fruman; Hagop M Kantarjian; Steven M Kornblau; Michael Andreeff; Marina Konopleva
Journal:  Oncotarget       Date:  2016-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.